Inspire Medical Systems, Inc. Increase (Decrease) in Inventories
Inspire Medical Systems, Inc. (INSP) reported Increase (Decrease) in Inventories of $25.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-03
- Inspire Medical Systems, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $4.22M, a 80.75% decline year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $20.94M, a 6.80% increase year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $3.52M, a 72.28% decline year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was $20.14M, a 139.58% increase year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in inventories for fiscal 2025 was $65.17M, a 40.97% increase from fiscal 2024.
- Inspire Medical Systems, Inc. increase (decrease) in inventories for fiscal 2024 was $46.23M, a 110.16% increase from fiscal 2023.
- Inspire Medical Systems, Inc. increase (decrease) in inventories for fiscal 2023 was $22.00M.
- Inspire Medical Systems, Inc. increase (decrease) in inventories for fiscal 2022 was -$5.34M, a 161.07% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $25.16M 10-Q · filed 2026-08-03 | $28.68M derived: sum of 3 quarters · filed 2026-08-03 | $48.82M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $20.94M 10-Q · filed 2026-05-04 | $24.46M derived: sum of 2 quarters · filed 2026-05-04 | $44.60M derived: sum of 3 quarters · filed 2026-05-04 | $66.51M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $23.66M derived: sum of 2 quarters · filed 2026-02-13 | $45.57M derived: sum of 3 quarters · filed 2026-08-03 | $65.17M 10-K · filed 2026-02-13 |
| 2025-09-30 | $20.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $42.05M derived: sum of 2 quarters · filed 2026-08-03 | $61.66M 10-Q · filed 2025-11-03 | $74.34M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $21.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $41.52M 10-Q · filed 2026-08-03 | $54.20M derived: sum of 3 quarters · filed 2026-08-03 | $62.61M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $19.61M 10-Q · filed 2026-05-04 | $32.30M derived: sum of 2 quarters · filed 2026-05-04 | $40.70M derived: sum of 3 quarters · filed 2026-05-04 | $50.75M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $12.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $21.09M derived: sum of 2 quarters · filed 2026-02-13 | $31.14M derived: sum of 3 quarters · filed 2026-02-13 | $46.23M 10-K · filed 2026-02-13 |
| 2024-09-30 | $8.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $18.46M derived: sum of 2 quarters · filed 2025-11-03 | $33.55M 10-Q · filed 2025-11-03 | $41.32M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $10.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $25.14M 10-Q · filed 2025-08-04 | $32.91M derived: sum of 3 quarters · filed 2026-02-13 | $38.18M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $15.09M 10-Q · filed 2025-05-05 | $22.86M derived: sum of 2 quarters · filed 2026-02-13 | $28.13M derived: sum of 3 quarters · filed 2026-02-13 | $33.31M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $7.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $13.04M derived: sum of 2 quarters · filed 2026-02-13 | $18.22M derived: sum of 3 quarters · filed 2026-02-13 | $22.00M 10-K · filed 2026-02-13 |
| 2023-09-30 | $5.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $10.45M derived: sum of 2 quarters · filed 2024-11-04 | $14.23M 10-Q · filed 2024-11-04 | $10.97M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $5.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $8.95M 10-Q · filed 2024-08-06 | $5.70M derived: sum of 3 quarters · filed 2025-02-10 | -$1.02M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $3.78M 10-Q · filed 2024-05-07 | $518.00K derived: sum of 2 quarters · filed 2025-02-10 | -$6.19M derived: sum of 3 quarters · filed 2025-02-10 | -$6.54M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | -$3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | -$9.97M derived: sum of 2 quarters · filed 2025-02-10 | -$10.31M derived: sum of 3 quarters · filed 2025-02-10 | -$5.34M 10-K · filed 2025-02-10 |
| 2022-09-30 | -$6.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$7.05M derived: sum of 2 quarters · filed 2023-11-07 | -$2.09M 10-Q · filed 2023-11-07 | -$429.00K derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | -$342.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $4.63M 10-Q · filed 2023-08-01 | $6.28M derived: sum of 3 quarters · filed 2024-02-09 | $8.56M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | $4.97M 10-Q · filed 2023-05-02 | $6.62M derived: sum of 2 quarters · filed 2024-02-09 | $8.90M derived: sum of 3 quarters · filed 2024-02-09 | $10.81M derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $3.94M derived: sum of 2 quarters · filed 2024-02-09 | $5.85M derived: sum of 3 quarters · filed 2024-02-09 | $8.75M 10-K · filed 2024-02-09 |
| 2021-09-30 | $2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $4.19M derived: sum of 2 quarters · filed 2022-11-01 | $7.09M 10-Q · filed 2022-11-01 | $6.61M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $4.82M 10-Q · filed 2022-08-02 | $4.33M derived: sum of 3 quarters · filed 2023-02-10 | $3.33M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $2.90M 10-Q · filed 2022-05-03 | $2.42M derived: sum of 2 quarters · filed 2023-02-10 | $1.42M derived: sum of 3 quarters · filed 2023-02-10 | $4.14M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | -$487.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$1.49M derived: sum of 2 quarters · filed 2023-02-10 | $1.23M derived: sum of 3 quarters · filed 2023-02-10 | $2.65M 10-K · filed 2023-02-10 |
| 2020-09-30 | -$999.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $1.72M derived: sum of 2 quarters · filed 2021-11-02 | $3.13M 10-Q · filed 2021-11-02 | $4.29M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $2.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $4.13M 10-Q · filed 2021-08-03 | $5.29M derived: sum of 3 quarters · filed 2022-02-15 | $6.40M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $1.41M 10-Q · filed 2021-05-04 | $2.57M derived: sum of 2 quarters · filed 2022-02-15 | $3.68M derived: sum of 3 quarters · filed 2022-02-15 | $4.14M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $2.27M derived: sum of 2 quarters · filed 2022-02-15 | $2.73M derived: sum of 3 quarters · filed 2022-02-15 | $3.17M 10-K · filed 2022-02-15 |
| 2019-09-30 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $1.57M derived: sum of 2 quarters · filed 2020-11-02 | $2.01M 10-Q · filed 2020-11-02 | $1.60M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $455.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $894.00K 10-Q · filed 2020-08-04 | $486.00K derived: sum of 3 quarters · filed 2021-02-24 | $13.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $439.00K 10-Q · filed 2020-05-05 | $31.00K derived: sum of 2 quarters · filed 2021-02-24 | -$442.00K derived: sum of 3 quarters · filed 2021-02-24 | -$288.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | -$408.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$881.00K derived: sum of 2 quarters · filed 2021-02-24 | -$727.00K derived: sum of 3 quarters · filed 2021-02-24 | -$1.00M 10-K · filed 2021-02-24 |
| 2018-09-30 | -$473.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$319.00K derived: sum of 2 quarters · filed 2019-11-05 | -$595.00K 10-Q · filed 2019-11-05 | $32.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $154.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$122.00K 10-Q · filed 2019-08-06 | $505.00K derived: sum of 3 quarters · filed 2020-02-25 | $538.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$276.00K 10-Q · filed 2019-05-07 | $351.00K derived: sum of 2 quarters · filed 2020-02-25 | $384.00K derived: sum of 3 quarters · filed 2020-02-25 | $201.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $627.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $660.00K derived: sum of 2 quarters · filed 2020-02-25 | $477.00K derived: sum of 3 quarters · filed 2020-02-25 | $315.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$150.00K derived: sum of 2 quarters · filed 2018-11-06 | -$312.00K 10-Q · filed 2018-11-06 | |
| 2017-06-30 | -$183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$345.00K 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | -$162.00K 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | -$612.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |